SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: limit who wrote (537)12/10/1997 8:37:00 PM
From: virgil vancleave  Read Replies (1) of 998
 
if you are buying them it might be an inexpensive play on the approval as the time frame is right. i would not be selling them even if you are doing covered calls. cause if either drug gets approved we will fly past 15 so fast it will be funny. this one was in the 20's on the prospects for myotropin (sp?) alone. company still has lots of cash and new products coming through the pipeline and it appear that when the
bad news dropped on it last year everyone forgot about it. if both drugs get approved with the low market cap, we could be up there with imnx and some of the rest. ceph wanted to go up all day today and the weak market held it back. strength in weakness is a good sign. hope the good trend and good news keeps up. the other factor i like is the fact that chiron is involved with them since chiron has more experience getting drugs approved. that could be a deciding factor. let's hope we are right. i am long but only have 500 shares
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News